Quarterly results for Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Limited
Quarterly Results Announcement: 01 August 2025
For the quarter ended 30 June 2025 (Q1 FY26)
Key Financial Metrics
Standalone (₹ Million):
- Revenue: ₹9,431.41 (↑8.2% YoY, ↑2.6% QoQ)
- EBITDA: ₹1,954.54 (↑14.8% YoY, ↓30.8% QoQ)
- EBITDA Margin: 20.7% (calculated)
- Net Profit: ₹873.71 (↑1.1% YoY, ↓45.4% QoQ)
- Net Profit Margin: 9.26% (↓0.65 pp YoY, ↓8.15 pp QoQ)
- EPS: ₹4.30 (↑1.2% YoY, ↓45.4% QoQ)
Consolidated (₹ Million):
- Revenue: ₹15,072.69 (↑15.4% YoY, ↑2.1% QoQ)
- EBITDA: ₹3,607.43 (↑10.7% YoY, ↓6.2% QoQ)
- EBITDA Margin: 23.9% (calculated)
- Net Profit (including discontinued operations): ₹1,967.07 (↓2.4% YoY, ↓0.3% QoQ)
- Net Profit Margin: 13.01% (↓2.02 pp YoY, ↓0.29 pp QoQ)
- EPS: Not disclosed
Balance Sheet Highlights (Q1 FY26)
- Total Assets: ₹73,831 million (Consolidated)
- Total Liabilities: ₹35,577 million (Consolidated)
- Debt-Equity Ratio: Standalone 0.65 (improved from 0.73 QoQ), Consolidated 0.58 (improved from 0.67 QoQ)
- Net Worth: Standalone ₹22,726 million; Consolidated ₹38,235 million
- Current Ratio: Standalone 1.41; Consolidated 2.03
Segment Performance (Consolidated)
- Medical & Healthcare Services: Revenue ₹15,070.62 million; Segment Profit ₹2,768.37 million
- Insurance Segment: Revenue ₹458.58 million; Segment Loss ₹240.46 million
- Inter-segment elimination: ₹(97.15) million
Management Commentary & Key Developments
- Merger scheme approved for Meridian Medical Research & Hospital Ltd. (MMRHL) with effective date 1 April 2024; pending NCLT filing.
- Board approved proposal to seek shareholder approval for issuance of debt securities (NCDs) up to ₹2,500 crore in FY26.
- Health City Cayman Islands Limited (HCCI) invested ₹146.39 million in a joint venture focused on cancer treatment centers in India.
- Narayana Vaishno Devi Specialty Hospitals Private Limited (NVD) classified as discontinued operations; ₹83.63 million impairment recorded in FY25 related to transfer of operations to Shri Mata Vaishno Devi Charitable Society effective 1 April 2026.
- No changes in accounting policies; clean auditor’s review report with no qualifications.
Outlook
- No explicit financial guidance provided for upcoming quarters.
- Strategic focus on consolidation via merger, expansion in specialty healthcare through JV, and potential capital raising via debt issuance.
This summary reflects Narayana Hrudayalaya Limited’s Q1 FY26 financial and operational status, highlighting growth trends, strategic initiatives, and balance sheet position for investment analysis.
Note: This is an AI generated summary of the results. There may be inaccuracies in the summary. Please refer to the original document before making investment decisions.